UK markets close in 1 hour 18 minutes

Ayala Pharmaceuticals, Inc. (ADXS)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.7200+0.0200 (+2.86%)
As of 10:21AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
Total revenue
1,733
3,506
3,708
Cost of revenue
1,643
3,506
3,708
Gross profit
90
0
0
Operating expenses
Research development
27,806
29,941
22,406
Selling general and administrative
9,826
9,277
7,371
Total operating expenses
37,632
39,218
29,777
Operating income or loss
-37,542
-39,218
-29,777
Interest expense
-
260
-
Income before tax
-37,766
-39,478
-29,721
Income tax expense
708
776
425
Income from continuing operations
-38,474
-40,254
-30,146
Net income
-38,474
-40,254
-30,146
Net income available to common shareholders
-38,474
-40,254
-30,146
Basic EPS
-2.51
-2.80
-3.06
Diluted EPS
-2.51
-2.80
-3.06
Basic average shares
15,325
14,399
9,861
Diluted average shares
15,325
14,399
9,861